HIV

HIV infection results in the production of an antibody that remains for life. Initial screening for HIV can now be undertaken without the need for a blood sample. The OraSure^® collection device collects a non-invasive oral sample which is ideal to identify blood borne viruses as part of a screening programme.

An initial antibody test is done for Anti-HIV antibody to HIV types 1, 2 & subtype 0. This means that wider screening of high risk groups can now be undertaken without unnecessarily exposing health care workers to risk.

If positive, a second confirmatory test is required to confirm the identity prior to issuing the result. It is recommended that this second test is undertaken with a blood sample. This blood sample can be used to provide further testing.